Back

Galectin-3 and ST-2 as predictors of therapeutic success in high-risk patients undergoing percutaneous mitral valve repair (MitraClip)

27 August 2017 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 2 - Mitral Valve Interventions Mitral valve interventions ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor Oliver Doerr

MVZ CCB Frankfurt und Main-Taunus GbR, Frankfurt am Main (Germany)

11 More presentations in this session

Presentation thumbnail
Associate Professor M. Spieker (Duesseldorf, DE)
Abstract Slides
Presentation thumbnail
Doctor B. Goebel (Bad Berka, DE)
Abstract
Presentation thumbnail
Doctor N. Ruozi (Reggio Nell'Emilia, IT)
Abstract Slides
Presentation thumbnail
Doctor K. Hellhammer (Duesseldorf, DE)
Abstract
Presentation thumbnail
Doctor D. Kalbacher (Hamburg, DE)
Abstract Slides

Access the full session

Session thumbnail
Poster session 2 - Mitral Valve Interventions

The Event

Event poster

ESC Congress 2017

27 August 2017 08:30 CET
You may be interested in
thumbnail
Congress Presentation
The role of NT ProBNP and Galectin 3 in the follow up of patients with primary mitral regurgitation
31 August 2025
thumbnail
Webinar
Structural heart interventions in aortic valvular disease - IC Core Curriculum 2
4 May 2022
thumbnail
Congress Presentation
Validation of expert criteria proposed by the "German Cardiac Society" for predicting procedural complexity in transcatheter edge-to-edge mitral valve repair
26 August 2022
thumbnail
Congress Session
From genetic signatures to clinical implications
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources